In vitro selection of nucleic acids and proteins: What are we learning?

Current Opinion in Structural Biology

Volumn 9, Issue 4, 1999, Pages 521-529

  Roberts, Richard W ^a   Ja, William W ^a  

^a California Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPOLYMER; NUCLEIC ACID; PROTEIN;

CATALYSIS; LIBRARY; MOLECULAR MIMICRY; MUTATION; NUCLEIC ACID STRUCTURE; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN STRUCTURE; REVIEW;

EID: 0033179060     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-440X(99)80074-8     Document Type: Article

References (112)

1. Szostak JW, Ellington RF: In vitro selection of functional RNA sequences. In The RNA World. Edited by Gesteland RF, Atkins JF. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1993:511-533.
2. Smith GP, Petrenko VA: Phage display. Chem Rev 1997, 97:391-410.
3. Jermutus L, Ryabova L, Plückthun A: Recent advances in producing and selecting functional proteins by using cell-free translation. Curr Opin Biotechnol 1998, 9:534-548.
4. Roberts RW, Szostak JW: RNA-peptide fusions for the in vitro selection of peptides and proteins. Proc Natl Acad Sci USA 1997, 94:12297-12302.
5. Liu R, Barrick J, Szostak JW, Roberts RW: Optimized synthesis of RNA-protein fusions for in vitro protein selection. Methods Enzymol 2000, 317:in press. This paper details significant improvements in the yield of mRNA-protein fusion synthesis. In addition, it is the first to demonstrate that a full-sized protein can be generated as a fusion and that RNA-binding peptides retain specificity as naked fusions.
6. Roberts RW: Totally in vitro protein selection using mRNA-protein fusions and ribosome display. Curr Opin Chem Biol 1999, 3:268-273.
7. Ellington A, Szostak JW: In vitro selection of RNA molecules that bind specific ligands. Nature 1990, 346:818-822.
8. GoLd L, Polisky B, Uhlenbeck O, Yarus M: Diversity of oligonucleotide functions. Annu Rev Biochem 1995, 64:763-797.
9. Willis MC, Collins B, Zhang T, Green LS, Sebesta DP, Bell C, Kellogg E, Gill SC, Magallanez A, Knauer S et al.: Liposome-anchored vascular endothelial growth factor aptamers. Bioconjug Chem 1998, 9:573-582.
10. Williams KP, Liu X-H, Schumacher TNM, Lin HY, Ausiello DA, Kim PS, Bartel DP: Bioactive and nuclease-resistant L-DNA ligand of vasopressin. Proc Natl Acad Sci USA 1997, 94:11285-11290.
11. Nakamura Y, Ito K, Isaksson LA: Emerging understanding of translation termination. Cell 1996, 87:147-150.
12. Wilson KS, Noller HF: Molecular movement inside the translational engine. Cell 1998, 92:337-349.
13. Pestova TV, Shatsky IN, Hellen CU: Functional dissection of eukaryotic initiation factor 4F: The 4A subunit and the central domain of the 4G subunit are sufficient to mediate internal entry of 43S preinitiation complexes. Mol Cell Biol 1996, 16:6870-6878.
14. Hentze MW: elF4G: A multipurpose ribosome adaptor? Science 1997, 275:500-501.
15. Schultz PG, Lerner RA: From molecular diversity to catalysis: Lessons from the immune system. Science 1995, 269:1835-1842.
16. Prudent JR, Uno T, Schultz PG: Expanding the scope of RNA catalysis. Science 1994, 264:1924-1927.
17. Conn MM, Prodent JR, Schultz PG: Porphyrin metallation catalyzed by a small RNA molecule. J Am Chem Soc 1996, 118:7012-7013.
18. Li Y, Sen D: A catalytic DNA for porphyrin metallation. Nat Struct Biol 1996, 3:743-747.
19. Noller HF, Hoffarth V, Zimniak L: Unusual resistance of peptidyl transferase to protein extraction procedures. Science 1992, 256:1416-1419.
20. Samaha RR, Green R, Noller HF: A base pair between tRNA and 23S rRNA in the peptidyl transferase centre of the ribosome. Nature 1995, 377:309-314.
21. Green R, Switzer C, Noller HF: Ribosome-catalyzed peptide-bond formation with an A-site substrate covalently linked to the 23S ribosomal RNA. Science 1998, 280:286-289.
22. Lohse PA, Szostak JW: Ribozyme-catalyzed amino-acid transfer reactions. Nature 1996, 381:442-444.
23. Wiegand TW, Janssen RC, Eaton BE: Selection of RNA amide synthesis. Chem Biol 1997, 4:675-683.
24. Zhang B, Cech TR: Peptide bond formation by in vitro selected ribozymes. Nature 1997, 390:96-100.
25. Zhang B, Cech TR: Peptidyl-transferase ribozymes: Trans reactions, structural characterization and ribosomal RNA-like features. Chem Biol 1998, 5:539-553. The secondary structure determination of clone 25 from [24] reveals its surprising homology to three distinct sequences in the peptidyl transferase center of the ribosome.
26. Welch M, Majerfeld I, Yarus M: 23S rRNA similarity from selection for peptidyl-transferase mimicry. Biochemistry 1997, 36:6614-6623.
27. Nitta I, Kamada Y, Noda H, Ueda T, Watanabe K: Reconstitution of peptide bond formation with Escherichia coli 23S ribosomal RNA domains. Science 1998, 281 :666-669.
28. -1).
29. Tuschl T, Sharp PA, Bartel DP: Selection in vitro of novel ribozymes from a partially randomized U2 and U6 snRNA library. EMBO J 1998, 17:2637-2650. The attempted resurrection of RNA molecules with spliceosomal activity. Four separate catalysts were isolated, none of which corresponds to the spliceosomal mechanism. Interestingly, one has a complex three-step mechanism.
30. Tarasow TM, Tarasow SL, Eaton BE: RNA-catalysed carbon-carbon bond formation. Nature 1997, 389:54-57.
31. Roth A, Breaker RR: An amino acid as a cofactor for a catalytic polynucleotide. Proc Natl Acad Sci USA 1998, 95:6027-6031. The first demonstration of free histidine as a necessary cofactor for a DNA-catalyzed (or RNA-catalyzed) reaction. The paper highlights the utility of enhancing the functional group diversity of nucleic acids.
32. Joyce GF: Nucleic acid enzymes: Playing with a fuller deck. Proc Natl Acad Sci USA 1998, 95:5845-5847.
33. Breaker RR: In vitro selection of catalytic polynucleotides. Chem Rev 1997. 97:371-390.
34. Santoro SW, Joyce GF: A general purpose RNA-cleaving DMA enzyme. Proc Natl Acad Sci USA 1997, 94:4262-4266.
35. Santoro SW, Joyce GF: Mechanism and utility of an RNA-cleaving DMA enzyme. Biochemistry 1998, 37:13330-13342.
36. Cuenoud B, Szostak JW: A DNA metalloenzyme with DNA ligase activity. Nature 1995, 375:611-614.
37. Breaker RR, Joyce GF: A DNA enzyme that cleaves RNA. Chem Biol 1995, 1:223-229.
38. Faulhammer D, Famulok M: Characterization and divalent metal-ion dependence of in vitro selected deoxyribozymes which cleave DNA/RNA chimeric oligonucleotides. J Mol Biol 1997, 269:188-202.
39. Geyer CR, Sen D: Evidence for the metal-cofactor independence of an RNA phosphodiester-cleaving DNA. Chem Biol 1997, 4:579-593.
40. Carmi N, Schultz LA, Breaker RR: In vitro selection of self-cleaving DNAs. Chem Biol 1996, 3:1039-1046.
41. Travascio P, Li Y, Sen D: DNA-enhanced peroxidase activity of a DNA aptamer-hemin complex. Chem Biol 1998, 5:505-517. The authors demonstrate that the N-methylmesoporphyrin DNA aptamer enhances the peroxidase activity of hemin by two orders of magnitude relative to free hemin.
42. Wilson C, Szoslak JW: Isolation of a fluorophore-specific DNA aptamer with weak redox activity. Chem Biol 1998, 5:609-617.
43. Li Y, Breaker RR: Phosphorylating DNA with DNA. Proc Natl Acad Sci USA 1999, 96:2746-2751. The authors describe the isolation of more than 50 different DNA enzymes that are capable of autophosphorylation. The enzymes in the pool demonstrate very high specificity for ATP as a substrate versus the other three nucleotides, or specificity between dNTPs versus NTPs.
44. Tang J, Breaker RR: Mechanism for allosteric inhibition of an ATP-sensitive ribozyme. Nucleic Acids Res 1998, 26:4214-4221.
45. Soukup GA, Breaker RR: Engineering precision RNA molecular switches. Proc Natl Acad Sci USA 1999, 96:3584-3589. The combination of aptamers with the hammerhead ribozyme in order to create artificial allosteric ribozymes is described.
46. Werstuck G, Green MR: Controlling gene expression in living cells through small molecule-RNA interactions. Science 1998, 282:296-298. The use of aptamer structures in the 5′-UTR (untranslated region) of mRNAs allows the down-regulation of translation in the presence of the small-molecule target.
47. Jencks WP: Binding energy, specificity, and enzymic catalysis: The Circe effect. Adv Enzymol Relat Areas Mol Biol 1975, 43:219-410.
48. Feigon J, Teikmann T, Smith FW: Aptamer structures from A to ζ. Chem Biol 1996, 3:611-617.
49. Patel DJ: Structural analysis of nucleic acid aptamers. Curt Opin Chem Biol 1997, 1:32-46.
50. Marshall KA, Robertson MP, Ellington AD: A biopolymer by any other name would bind as well: A comparison of the ligand-binding pockets of nucleic acids and proteins. Structure 1997, 5:729-734.
51. Nowakowski J, Shim PJ, Prasad GS, Stout CD, Joyce GF: Crystal structure of an 82-nucleotide RNA-DNA complex formed by the 10-23 DNA enzyme. Nat Struct Biol 1999, 6:151-156. An interesting nucleic acid structure is described that probably does not conform to the actual geometry of the 10-23 DMA enzyme.
52. Wedekind JE, McKay DB: Crystal structure of a lead-dependent ribozyme revealing metal binding sites relevant to catalysis. Nat Struct Biol 1999, 6:261-268. The first crystal structure determination of a laboratory-isolated RNA enzyme. The structure contains two molecules, one of which is in a precatalytic geometry that can be used to rationalize the cleavage chemistry.
53. McKay DB: Structure and function of the hammerhead ribozyme: An unfinished story. RNA 1996, 2:395-403.
54. Verma S, Vaish NK, Eckstein F: Structure-function studies of the hammerhead ribozyme. Curr Opin Chem Biol 1997, 1:532-536.
55. Golden BL, Gooding AR, Podell ER, Cech TR: A preorganized active site in the crystal structure of the Tetrahymena ribozyme. Science 1998, 282:259-264.
56. Ferre-D'Amare AR, Zhou K, Doudna JA: Crystal structure of a hepatitis delta virus ribozyme. Nature 1998, 395:567-574.
57. Griffiths AD, Duncan AR: Strategies for selection of antibodies by phage display. Curr Opin Biotechnol 1998, 9:102-108. An excellent review of antibodies displayed on phage.
58. Spada S, Plückthun A: Selectively infective phage (SIP) technology: A novel method for in vivo selection of interacting protein-ligand pairs. Nat Med 1997, 3:694-696.
59. Tsang J, Joyce GF: In vitro evolution of randomized ribozymes. Methods Enzymol 1996, 267:410-426.
60. Crameri A, Raillard SA, Bermudez E, Stemmer WPC: DMA shuffling of a family of genes from diverse species accelerates directed evolution. Nature 1998, 391:288-291. In vitro shuffling of four related cephalosporinase genes produced a recombinant with greatly enhanced activity in fewer cycles than through mutagenesis and recombination of the individual genes.
61. Zhao HM, Giver L. Shao ZX, Aftholter JA, Arnold FH: Molecular evolution by staggered extension process (STEP) in-vitro. Nat Biotechnol 1998, 16:258-261. Short cycles of annealing and extension in a PCR-like reaction produce prematurely terminated products that can randomly anneal to parent strands in the next cycle, creating recombinant sequences. This novel method was used to evolve a subtilisin E variant that is equivalent to its thermophilic homolog.
62. Tawfik DS, Griffiths AD: Man-made cell-like compartments for molecular evolution. Nat Biotechnol 1998, 16:652-656. In vitro transcription and translation were linked via compartmentalization in reverse micelles. A selection for targeted DNA methylation using Haelll methyltransferase was demonstrated.
63. Hanes J, Pluckthun A: In vitro selection and evolution of functional proteins by using ribosome display. Proc Natl Acad Sci USA 1997, 94:4937-4942.
64. Hanes J, Jermutus L, Weber-Bornhauser S, Bosshard HR, Plückthun A: Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries. Proc Natl Acad Sci USA 1998, 95:14130-14135. The first report of the construction and implementation of an immunized murine scFv library using ribosome display. The best clone appears to have 65-fold higher affinity than the sequence it was derived from.
65. Stemmer WPC: DNA shuffling by random fragmentation and reassembly: In vitro recombination for molecular evolution. Proc Natl Acad Sci USA 1994, 91:10747-10751.
66. Shao Z, Zhao H, Giver L, Arnold FH: Random-priming in vitro recombination: An effective tool for directed evolution. Nucleic Acids Res 1998, 26:681-683.
67. Matsuura T, Miyai K, Trakulnaleamsai S, Yomo T, Shima Y, Miki S, Yamamoto K, Urabe I: Evolutionary molecular engineering by random elongation mutagenesis. Nat Biotechnol 1999, 17:58-61.
68. Driggers EM, Liu CW, Wemmer DE, Schultz PG: Structure of the Michaelis complex of an efficient antibody acyl transferase determined by transferred nuclear Overhauser enhancement spectroscopy. J Am Chem Soc 1998, 120:7395-7396. Transferred NOE experiments were used to determine the structure of two bound substrates in the presence of an acyl transferase antibody.
69. 15N-labeled protein indicate the sites of peptide interaction, suggesting a binding 'hot spot' that can be readily targeted.
70. Wiesmann C, Christinger HW, Cochran AG, Cunningham BC, Fairbrother WJ, Keenan CJ, Meng G, de Vos AM: Crystal structure of the complex between VEGF and a receptor-blocking peptide. Biochemistry 1998, 37:17765-17772. One of the selected peptides in [69••] was crystallized bound to VEGF. The peptide adopts a largely extended conformation resembling Fab fragment interaction more closely than the VEGF-receptor interaction.
71. Kay BK, Kurakin AV, Hyde-DeRuyscher R: From peptides to drugs via phage display. Drug Discovery Today 1998, 3:370-378.
72. Sparks AB, Hoffman NG, McConnell SJ, Fowlkes DM, Kay BK: Cloning of ligand targets: Systematic isolation of SH3 domain-containing proteins. Nat Biotechnol 1996, 14:741-744.
73. Sparks AB, Rider JE, Hoffman NG, Fowlkes DM, QuilLam LA, Kay BK: Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, cortactin, p53bp2, PLCγ, Crk, and Grb2. Proc Natl Acad Sci USA 1996, 93:1540-1544.
74. Pasqualini R, Koivunen E, Ruoslahti E: αv Integrins as receptors for tumor targeting by circulating ligands. Nat Biotechnol 1997, 15:542-546.
75. Pierce HH, Schachat F. Brandt PW, Lombardo CR, Kay BK: Identification of troponin C antagonists from a phage-displayed random peptide library. J Biol Chem 1998, 273:23448-23453.
76. Spolar RS, Ha J-H, Record MTJ: Hydrophobic effect in protein folding and other noncovalent processes involving proteins. Proc Natl Acad Sci USA 1989, 86:8382-8385.
77. Wrighton NC, Farrell FX, Chang R, Kashyap AK, Barbone FP, Mulcahy LS, Johnson DL, Barrett RW, Jolliffe LK, Dower WJ: Small peptides as potent mimetics of the protein hormone erythropoietin. Science 1996, 273:458-463.
78. Livnah O, Stura EA, Johnson DL, Middleton SA, Mulcahy LS, Wrighton NC, Dower WJ, Jolliffe LK, Wilson IA: Functional mimicry of a protein hormone by a peptide agonist: The epo receptor complex at 2.8 Å. Science 1996, 273:464-471.
79. Johnson DL, Farrell FX, Barbone FP, McMahon FJ, Taullai J, Hoey K, Livnah O, Wrighton NC, Middleton SA, Loughney DA et al.: Identification of a 13 amino acid peptide mimetic of erythropoietin and description of amino acids critical for the mimetic activity of EMP1. Biochemistry 1998, 37:3699-3710. Alanine scanning and truncation were applied to the erythropoietin mimetic peptides (EMPs) isolated previously, resulting in a 13 amino acid sequence containing the minimal agonist epitope.
80. Cwirla SE, Balasubramanian P, Duffin DJ, Wagstrom CR, Gates CM, Singer SC, Davis AM, Tansik RL, Mattheakis LC, Boytos CM et al.: Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine. Science 1997, 276:1696-1699.
81. Starovasnik MA, Braisted AC, Wells JA: Structural mimicry of a native protein by a minimized binding domain. Proc Natl Acad Sci USA 1997, 94:10080-10085.
82. Clackson T, Wells JA: A hot spot of binding energy in a hormone-receptor interface. Science 1995, 267:383-386.
83. Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G: By-passing immunization: Human antibodies from V-gene libraries displayed on phages. J Mol Biol 1991, 222:581-597.
84. Griffiths AD, Malmqvist M, Marks JD, Bye JM, Embleton MJ, McCafferty J, MAier M, Holliger KP, Gorick BD, Hughs-Jones NC et al: Human anti-self antibodies with high specificity from phage display libraries. EMBO J 1993, 12:725-734.
85. Vaughan TJ, Williams AJ, Pritchard K, Osbourn JK, Pope AR, Earnshaw JC, McCafferty J, Hodits RA, Wilton J, Johnson KS: Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat Biotechnol 1996, 14:309-314.
86. Lancet D, Sadovsky E, Seidemann E: Probability model for molecular recognition in biological receptor repertoires: Significance to the olfactory system. Proc Natl Acad Sci USA 1993, 90:3715-3719.
87. Smith GP, Patel SU, Windass JD, Thornton JM, Winter G, Griffiths AD: Small binding proteins selected from a combinatorial repertoire of knottins displayed on phage. J Mol Biol 1998, 277:317-332. The knottins represent some of the smallest proteins known. These sequences maintain their folded conformations due to the presence of disulfide bonds (typically 2-3 out of 30 amino acids) and have potential as scaffolds to display chemical diversity. The authors screened a cellulose-binding knottin library and derived binders for alkaline phosphatase (see Table 2).
88. Beste G, Schmidt FS, Stibora T, Skerra A: Small antibody-like proteins with prescribed ligand specificities derived from the lipocalin fold. Proc Natl Acad Sci USA 1999, 96:1898-1903. The authors demonstrated that lipocalins may represent an alternate framework to antibodies for developing general binding proteins via in vitro selection.
89. Baca M, Scanlan TS, Stephenson RC, Wells JA: Phage display of a catalytic antibody to optimize affinity for transition-state analog binding. Proc Natl Acad Sci USA 1997, 94:10063-10068.
90. Arkin MR, Wells JA: Probing the importance of second sphere residues in an esterolytic antibody by phage display. J Mol Biol 1998, 284:1083-1094. Phage display was used to improve and probe esterolytic antibody function. The report provides another example in which residues remote from the active site are important for binding and catalysis. A correlation is seen between transition state analog binding and catalytic function for single mutations.
91. Fujii I. Fukuyama S, Iwabuchi Y, Tanimura R: Evolving catalytic antibodies in a phage-displayed combinatorial library. Nat Biotechnol 1998, 16:463-467.
92. Gao C, Lavey BJ, Lo C-HL, Datta A, Wentworth PJ: Direct selection for catalysis from combinatorial antibody libraries using a boronic acid probe: Primary amide bond hydrolysis. J Am Chem Soc 1998, 120:2211-2217.
93. Wirsching P. Ashley JA, Lo C-HL, Janda KD, Lerner RA: Reactive immunization. Science 1995, 270:1775-1782.
94. Barbas CFI, Heine A, Zhong G, Hoffmann T, Gramatikova S, Bjornestedt R, List B, Anderson J, Stura EA, Wilson IA, Lerner RA: Immune versus natural selection: Antibody aldolases with enzymatic rates but broader scope. Science 1997, 278:2085-2092.
95. Janda KD, Lo L-C, Lo C-HL, Sim M-M, Wang R, Wong C-H, Lerner RA: Chemical selection for catalysis in combinatorial antibody libraries. Science 1997, 275:945-948.
96. Pedersen H, Hölder S, Sutherlin DP, Schwitter U, King DS, Schultz PG: A method for directed evolution and functional cloning of enzymes. Proc Natl Acad Sci USA 1998, 95:10523-10528. A novel strategy for the direct selection of catalysts by phage display is demonstrated by attaching both the enzyme and substrate to the coat protein of phage. Intramolecular catalysis provides the basis for selection. A model enrichment using staphylococcal nuclease is demonstrated.
97. Demartis S, Huber A, Viti F, Lozzi L, Giovannoni L, Neri P, Winter G, Neri D: A strategy for the isolation of catalytic activities from repertoires of enzymes displayed on phage. J Mol Biol 1999, 286:617-633.
98. Patten PA, Gray NS, Yang PL, Marks CB, Wedemayer GJ, Boniface JJ, Stevens RC, Schultz PG: The immunological evolution of catalysis. Science 1996, 271:1086-1091.
99. Wedemayer GJ, Patten PA, Wang LH, Schultz PG, Steven RC: Structural insights into the evolution of an antibody combining site. Science 1997 276:1665-1669.
100. Oue S, Okamoto A, Yano T, Kagamiyama H: Redesigning the substrate specificity of an enzyme by cumulative effects of the mutations of non-active site residues. J Biol Chem 1999, 274:2344-2349.
101. Romesberg FE, Spiller B, Schultz PG, Stevens RC: Immunological origins of binding and catalysis in a Diels-Alderase antibody. Science 1998, 279:1929-1933.
102. Cordes MHJ, Walsh NP, McKnight CJ, Sauer RT: Evolution of a protein fold in vitro. Science 1999, 284:325-327. The substitution of two residues into the Arc repressor changes the local secondary structure from a β sheet to a short α helix, with the preservation of core packing. The results imply that modest changes in amino acid sequence may allow significant changes in local secondary structure
103. Jones JT, Ballinger MD, Pisacane PI, Lofgren JA, Fitzpatrick VD, Fairbrother WJ, Wells JA, Sliwkowski MX: Binding interaction of the heregulinβ egf domain with ErbB3 and ErbB4 receptors assessed by alanine scanning mutagenesis. J Biol Chem 1998, 273:11667-11674. A thorough study of protein specificity through exhaustive alanine scanning mutagenesis.
104. Ballinger MD, Jones JT, Lofgren JA, Fairbrother WJ, Akita RW, Sliwkowski MX, Wells JA: Selection of heregulin variants having higher affinity for the ErbB3 receptor by monovalent phage display. J Biol Chem 1998, 273:11675-11684. Variants of a growth factor domain with higher affinities for its receptor revealed that beneficial mutations generally avoided critical binding residues. Evolved proteins had enhanced affinity either by reconfiguring essential binding residues or by forming new contacts.
105. Elrod-Erikson M, Benson TE, Pabo CO: High-resolution structures of variant Zif268-DNA complexes: Implications for understanding zinc finger-DNA recognition. Structure 1998, 6:451-464. A thorough structural analysis of zinc-finger-DNA variants revealed the difficulties in determining an exhaustive recognition code defining zinc-finger DNA-binding specificity. The results cast serious doubt on developing a code for sequence-specific protein-DNA recognition.
106. Street AG, Mayo SL: Computational protein design. Structure 1999, 7:R105-R109.
107. Rodi DJ, Janes RW, Sanganee HJ, Holton RA, Wallace BA, Makowski L: Screening of a library of phage-displayed peptides identifies human Bcl-2 as a taxol-binding protein. J Mol Biol 1999, 285:197-203.
108. Fukumoto T, Torigoe N, Kawabata S, Murakami M, Uede T, Nishi T, Ito Y, Sugimura K: Peptide mimics of the CTLA4-binding domain stimulate T-cell proliferation. Nat Biotechnol 1998, 16:267-270.
109. Rand KH, Houck H. Denslow ND, Heilman KM: Molecular approach to find target(s) for oligoclonal bands in multiple sclerosis. J Neurol Neurosurg Psychiatry 1998, 65:48-55.
110. Bremnes T, Lauvrak V, Lindqvist B. Bakke O: Selection of phage displayed peptides from a random 10-mer library recognising a peptide target. Immunotechnol 1998. 4:21-28.
111. Gårdsvoll H, van Zonneveld A-J, Holm A, Eldering E, van Meijer M, Danoø K, Pannekoek H: Selection of peptides that bind to plasminogen activator inhibitor 1 (PAI-1) using random peptide phage-display libraries. FEBS Lett 1998, 431:170-174.
112. Pearce KHJ, Cunningham BC, Fuh G, Teeri T, Wells JA: Growth hormone binding affinity for its receptor surpasses the requirements for cellular activity. Biochemistry 1999, 38:81-89.